Editorial Team
Abstract
Dear readers and authors, Even pandemic times, the Editorial Team hopes to find them all well. In 2017, we started the trajectory of this journal with courage and enthusiasm, contributing to advancement of analytical science in different areas of pharmaceutical research. Over these five years of learning and improvement, we are consolidating step by step this digital means of communication that aims to disseminate and update perspectives of drug analysis in different matrices. The first issue of 2021 celebrates our fifth year of existence and stands out for the inclusion of two manuscripts from abroad and two review manuscripts. The journal's layout also received innovations in reference to this date. Finally, we would like to point out that the journal is indexed by Diadorim, DOAJ and Google Scholar, and is currently classified as Qualis C by CAPES. Thanks to those who have been with us these five years and be most welcome if you are new here. We wish you all an excellent reading.
Downloads
Downloads
Published
Versions
- 18-03-2026 (2)
- 30-06-2021 (1)
How to Cite
Issue
Section
License
Copyright (c) 2021 Drug Analytical Research

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Copyright holder of manuscripts published is Drug Analytical Research. Authors who publish with this journal are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Licensing:
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.





